Loading data
LIMNNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Research and development expense | — | 2.69 m USD | 3.76 m USD |
| Operating profit | -2.97 m USD | -3.33 m USD | -4.82 m USD |
| Net income (reported basis) | -10.21 m USD | -3.55 m USD | -4.98 m USD |
| Basic earnings per share | -0.43 USD/share | -0.2 USD/share | — |
| Diluted earnings per share | -0.43 USD/share | -0.2 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.